Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Can improvement in therapy decrease the rate of death due to lung cancer?]

T Kasai1, N Saijo

  • 1Department of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan.

Nihon Kyobu Shikkan Gakkai Zasshi
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Lung cancer treatment is improving with new chemotherapy drugs and radiation timing strategies. Research focuses on novel therapies like gene therapy and dose-intensive chemotherapy for better patient outcomes.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Induction chemotherapy followed by gefitinib and concurrent thoracic radiotherapy for unresectable locally advanced adenocarcinoma of the lung: a multicenter feasibility study (JCOG 0402).

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

Randomised, phase III trial of epoetin-β to treat chemotherapy-induced anaemia according to the EU regulation.

British journal of cancer·2011
Same author

Cross-resistance to antineoplastic agents in a human small-cell lung-cancer subline resistant to okadaic Acid.

Oncology reports·2011
Same author

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

Oncogene·2011
Same author

A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606).

British journal of cancer·2010

Area of Science:

  • Oncology
  • Medical Research
  • Cancer Therapeutics